Macquarie Park, Australia

Collette Behrens

USPTO Granted Patents = 7 



Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Collette Behrens: Innovator in Cancer Treatment

Introduction

Collette Behrens is a notable inventor based in Macquarie Park, Australia. She has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 7 patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

One of her latest patents is titled "Interferon alpha 2B variants." This invention provides a fusion polypeptide that includes a first domain comprising a polypeptide ligand that binds to a cell surface-associated antigen. The second domain consists of aglycosylated interferon alpha 2b (IFNα2b) with specific sequences. The aglycosylated IFNα2b also includes amino acid substitutions or deletions that attenuate its activity. Another significant patent is "Combination of lenalidomide and polypeptide construct, and uses thereof." This patent outlines methods for cancer treatment that involve administering an anti-CD38 antibody-attenuated human IFN alpha-2b construct along with lenalidomide or pomalidomide. The tumors targeted by these methods include those with CD-38 expressing tumor cells, such as B-cell lymphoma and multiple myeloma.

Career Highlights

Collette has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceuticals Australia Pty Ltd and Teva Pharmaceuticals Pty Ltd. Her experience in these organizations has contributed to her expertise in developing innovative treatments.

Collaborations

Throughout her career, Collette has collaborated with talented individuals such as Anthony Gerard Doyle and Sarah Lee Pogue. These partnerships have likely enhanced her research and development efforts.

Conclusion

Collette Behrens is a pioneering inventor whose work in cancer treatment showcases her dedication to improving patient outcomes. Her innovative patents and collaborations highlight her significant contributions to the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…